Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

PaperCitations, authors & open-access status

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 157 citations, 2016 year and bronze oa status.